New Faculty and APP Additions – 2025
The Department of Internal Medicine is pleased to introduce some of the newest members, most of whom joined us between October and December 2025 (start…
Author: Internal Medicine at Iowa
-
-
Sadasivam joins ALA team to investigate lung cancer immunotherapy
Protected time and project funding play a critical role in supporting early-career investigators as they pursue innovative research. Mohanraj Sadasivam, PhD, a researcher in the…
-
Residency recognition & holiday party, 2026
The past four months, the Internal Medicine Residency Program conducted hundreds of interviews with trainee applicants. Although some second-look visits from applicants are yet to…
-
A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults
Article: A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults Authors: Patricia Winokur, Theresa…
-
Celebrating Mark Wilson’s career, contributions
Earlier this week, the Divisions of Hospital Medicine and of General Internal Medicine, and the Internal Medicine Residency Program hosted an event in the Medical…
-
Eliminating treatment barriers with theratyping
For Alejandro Pezzulo, MD, associate professor in Pulmonary, Critical Care, and Occupational Medicine, one of the most rewarding moments in his career transpired during a…
-
Overlooked and Underdiagnosed: Cardiac Sarcoidosis and Unexplained Ventricular Tachycardia and Fibrillation
Article: Overlooked and Underdiagnosed: Cardiac Sarcoidosis and Unexplained Ventricular Tachycardia and Fibrillation Authors: Aaron A Sifuentes, Ghazaleh Goldar, Usamah M ElBakkush, Kaushik Gokul, Mohammed Mhanna,…
-
Division holiday parties, 2026
A couple of our divisions and our residency program have traditionally held winter parties every year. But this year many of our divisions took the…
-
Robinson investigates how care models influence incretin therapy outcomes
Incretin-based therapies, such as GLP-1s and GIPs, have transformed treatment for people with Type II Diabetes (T2D) and obesity. In turn, many clinicians have harnessed…
-
Streit named Infectious Diseases division director
The below announcement was sent to the Department of Internal Medicine earlier today by Chair & DEO Upinder Singh, MD. It is my great pleasure…
